Objective Cardiovascular diseases (CVD) remain the leading cause of mortality globally, necessitating early risk identification to improve prevention and management strategies. Traditional risk ...
Visit Vektor Medical at Booth 208 to Learn More about vMap®, the VITAL-EP Registry’s AF Findings, and the Newly Released Atrial Flutter Workflow At this year’s meeting, a featured study titled "High ...
BOSTON--(BUSINESS WIRE)--Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced its participation in AF Symposium 2026, taking place February 5–8 in Boston, ...
3d
Patients with atrial fibrillation face higher bleeding risks when treated with 2 common medications
Patients with atrial fibrillation who are prescribed diltiazem to control heart rate alongside anticoagulants (blood thinners ...
Vektor Medical to Showcase VITAL-EP Registry’s Atrial Fibrillation Results, Including Fast, Zero-Fluoro PVI+ Ablation Workflow, and New Atrial Flutter Capabilities Visit Vektor Medical at Booth 208 to ...
Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced its participation in AF Symposium 2026, taking place February 5–8 in Boston, where new clinical data ...
Midland Daily News on MSN
MyMichigan Health: What to know about atrial fibrillation - signs, risks and treatment options
Lu Chen, M.D., is a cardiologist specializing in electrophysiology with MyMichigan Physicians Group.
Atrial fibrillation, or A-fib, is becoming more common, but doctors say treatments are improving. The condition is a quivering or irregular heartbeat that can lead to blood clots, stroke and heart ...
Peer-reviewed paper indicates icosapent ethyl (IPE) was associated with fewer total hospitalizations and fewer days lost due to hospitalization ...
Daniel Moore was about 30 the first time it happened. At the end of a long, hot, stressful day, he chugged an ice-cold glass of milk. “It felt like a bunny rabbit trying to jump out ...
The Trump administration finally has unveiled TrumpRx.gov, a website for consumers to find discounts on brand-name drugs if they pay cash instead of using their health insurance. It launched Thursday ...
The U.S. Food and Drug Administration said on Friday it would take action against telehealth provider Hims & Hers for its $49 weight-loss pill, including restricting access to the drug's ingredients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results